Syed Ali-aamir Rizvi

Insider Reports History

Entity
Individual
Location
C/O Poseida Therapeutics, 9390 Towne Centre Drive, Suite 200, San Diego, CA
Signature
/s/ Johanna Mylet, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Syed Ali-aamir Rizvi:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Caribou Biosciences, Inc. Chief Medical Officer Option to purchase Common Stock 131K $352K $2.69 Feb 21, 2023 Direct
Caribou Biosciences, Inc. Chief Medical Officer Common Stock 59.4K $176K $2.96 Jan 19, 2023 Direct
Poseida Therapeutics, Inc. Chief Medical Officer Common Stock 0 $0 $9.60 Jan 8, 2025 Direct
Poseida Therapeutics, Inc. Chief Medical Officer Employee Stock Option (Right to Buy) 250K Apr 1, 2024 Direct
Poseida Therapeutics, Inc. Chief Medical Officer Employee Stock Option (Right to Buy) 0 Jan 8, 2025 Direct

Insider Reports Filed by Syed Ali-aamir Rizvi

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PSTX Poseida Therapeutics, Inc. Jan 8, 2025 2 $0 4 Jan 8, 2025 Chief Medical Officer
PSTX Poseida Therapeutics, Inc. Apr 1, 2024 2 $0 4 Apr 3, 2024 Chief Medical Officer
PSTX Poseida Therapeutics, Inc. Apr 1, 2024 0 $0 3 Apr 3, 2024 Chief Medical Officer
CRBU Caribou Biosciences, Inc. Feb 21, 2023 1 $0 4 Feb 23, 2023 Chief Medical Officer
CRBU Caribou Biosciences, Inc. Jan 19, 2023 1 -$35.5K 4 Jan 20, 2023 Chief Medical Officer
CRBU Caribou Biosciences, Inc. Jan 25, 2022 2 $0 4 Jan 25, 2022 Chief Medical Officer
CRBU Caribou Biosciences, Inc. Jan 18, 2022 0 $0 3 Jan 24, 2022 Chief Medical Officer